Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class I · High risk

FentaNYL citrate PF

Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Ongoing Wrong potency / content Denver Solutions, LLC DBA Leiters Health NDC 71449-072-82 D-0278-2024
Class I · High risk

FentaNYL citrate PF

Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Ongoing Wrong potency / content Denver Solutions, LLC DBA Leiters Health NDC 71449-072-41 D-0277-2024
Class II · Moderate risk

Premier Value Tussin Cough DM

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Ongoing Microbial contamination Seaway Pharma Inc. D-0215-2024
Class III · Low risk

Benzonatate Capsules

Superpotent drug: Assay results were slightly above specification at the time zero point.

Ongoing Wrong potency / content Amerisource Health Services LLC NDC 68084-214-01 D-0257-2024
Class I · High risk

Americaine

Chemical Contamination: presence of benzene

Completed Chemical / undeclared Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company NDC 63736-378-02 D-0236-2024

Recalls by year